БОРТЕРО
Активний інгредієнт: Bortezomib
Опис товару
About БОРТЕРО
БОРТЕРО is a prescription medication containing the active ingredient Bortezomib, used in the treatment of multiple myeloma and mantle cell lymphoma. It is a proteasome inhibitor that works by blocking the action of proteasomes, which are responsible for breaking down proteins in cells.
Key Benefits & Uses
- Treatment of multiple myeloma, including relapsed and refractory disease
- Treatment of mantle cell lymphoma
- Indicated for patients who have received at least one prior therapy
Active Ingredient & Action
Bortezomib works by binding to the 26S proteasome, a large protein complex that degrades ubiquitinated proteins. By inhibiting the proteasome, Bortezomib disrupts the normal functioning of cells, leading to cell cycle arrest and apoptosis. This results in the reduction of tumor cell growth and proliferation.
Important Notes
БОРТЕРО is available in injectable form and should be administered under the guidance of a healthcare professional. Patients should be closely monitored for signs of peripheral neuropathy, fatigue, and other adverse effects. It is essential to follow the recommended dosing schedule and to report any concerns or side effects to a healthcare provider.
Оцінки відвідувачів
Допоможіть іншим — оцініть корисність цієї сторінки.
Оцінок ще немає — будьте першим.
